-
Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Cardiovascular Amarin said it launched Vascepa icosapent ethyl in the U.S. as an adjunct to diet to reduce triglyceride levels in adults with severe …
Published on 2/4/2013
-
Arup Laboratories, Salt Lake City, Utah Counsyl Inc., South San Francisco, Calif. Business: Diagnostic Arup partnered with Counsyl to include the Counsyl Test in Arup's pre-pregnancy and early pregnancy genetic test …
Published on 2/4/2013
-
D&A Pharma, Paris, France Imaxio S.A., Saint-Beauzire, France Business: Endocrine/Metabolic D&A granted Imaxio rights to congenital metabolic disease drug Trolovol d-penicillamine in France. The chelator is marketed in …
Published on 2/4/2013
-
Epigenomics AG (Xetra:ECX), Berlin, Germany Predictive Biosciences Inc., Lexington, Mass. Business: Diagnostic The partners said Predictive Biosciences launched a biopsy test to diagnose prostate cancer in the U.S. that…
Published on 2/4/2013
-
Exelixis Inc. (NASDAQ:EXEL), South San Francisco, Calif. Business: Cancer Exelixis launched Cometriq cabozantinib in the U.S. to treat progressive, metastatic medullary thyroid cancer (MTC). The wholesale acquisition …
Published on 2/4/2013
-
Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands General Electric Co. (NYSE:GE), Fairfield, Conn. Business: Pharmacogenetics Qiagen said General Electric's Clarient Diagnostic Services Inc. company will now …
Published on 2/4/2013
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Cardiovascular, Inflammation Sanofi launched LeGoo gel in the U.S. for temporary endovascular occlusion of blood vessels during surgical procedures. The pharma …
Published on 2/4/2013
-
SciClone Pharmaceuticals Inc. (NASDAQ:SCLN), Foster City, Calif. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Neurology, Cardiovascular, Genitourinary SciClone announced that it and Sanofi agreed to group …
Published on 2/4/2013
-
BioPorto Diagnostics A/S (CSE:BIOPOR), Gentofte, Denmark Siemens AG (Euronext:SIE; NYSE:SI), Munich, Germany Business: Diagnostic BioPorto received notification from Siemens that it halted sale activities concerning …
Published on 1/28/2013
-
Hybrigenics S.A. (Euronext:ALHYG), Paris, France Business: Proteomics, Supply/Service Hybrigenics' Hybrigenics Services subsidiary launched a worldwide service to identify interactions between small molecules and …
Published on 1/28/2013
-
KV Pharmaceutical Co. (OTCQB:KVPHQ), St. Louis, Mo. Perrigo Co. (NASDAQ:PRGO; Tel Aviv:PRGO), Allegan, Mich. Business: Infectious KV's Ther-Rx Corp. subsidiary and Perrigo relaunched Gynazole-1 butoconazole nitrate …
Published on 1/28/2013
-
Merck KGaA (Xetra:MRK), Darmstadt, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Autoimmune Merck's Merck Serono S.A. division and Pfizer launched a $0 co-pay program for Rebif interferon beta-1a to treat …
Published on 1/28/2013
-
Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario POA Pharma Scandinavia AB, Gothenburg, Sweden Proximum d.o.o., Zagreb, Croatia SPCare Lda, Lisbon, Portugal Business: Genitourinary Merus granted …
Published on 1/28/2013
-
Recordati S.p.A. (Milan:REC), Milan, Italy H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Neurology, Cardiovascular Recordati completed its acquisition of a portfolio of H. Lundbeck's non-core products. …
Published on 1/28/2013
-
Vitro Diagnostics Inc. (OTCBB:VODG), Golden, Colo. Business: Gene/Cell therapy, Supply/Service Vitro launched native and labeled osteoblasts derived from human mesenchymal stem cells (MSCs) worldwide for use in …
Published on 1/28/2013
-
Werfen Group S.A., Barcelona, Spain Business: Diagnostic Werfen's Inova Diagnostics Inc. subsidiary launched its Bio-Flash chemiluminescent analyzer worldwide to aid in diagnosing autoimmune disease. The product uses …
Published on 1/28/2013
-
AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Autoimmune AbbVie launched Humira adalimumab in the U.K. to treat patients aged 6-17 years with severely active Crohn's disease who failed, are intolerant to or have …
Published on 1/21/2013
-
Apeiron Biologics AG, Vienna, Austria Paladin Labs Inc. (TSX:PLB), Montreal, Quebec Business: Cancer Apeiron granted Paladin exclusive rights to commercialize APN311, a chimeric mAb against GD2, in Canada and sub-…
Published on 1/21/2013
-
Atossa Genetics Inc. (NASDAQ:ATOS), Seattle, Wash. Business: Diagnostic Atossa launched its ForeCYTE Breast Health Test in the U.S. to differentiate between normal, premalignant and malignant tumor cells as an adjunct …
Published on 1/21/2013
-
Duchesnay Inc., Blainville, Quebec Tzamal Medical Group Ltd., Petah Tikva, Israel Business: Gastrointestinal Duchesnay granted Tzamal exclusive rights to commercialize Diclectin doxylamine/pyridoxine in Israel to manage…
Published on 1/21/2013
-
Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Teijin Pharma Ltd., Tokyo, Japan Business: Endocrine/Metabolic Teijin launched Somatuline lanreotide acetate in Japan to treat acromegaly and …
Published on 1/21/2013
-
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Cambridge, Mass. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Gastrointestinal Ironwood said in its 4Q12 earnings that it received rights from AstraZeneca to …
Published on 1/21/2013
-
Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Laboratory Corp. of America Holdings (NYSE:LH), Burlington, N.C. Business: Diagnostic Johnson & Johnson's Veridex LLC unit granted LabCorp rights to use CellSearch …
Published on 1/21/2013
-
Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Neurology Pfizer launched Quillivant XR in the U.S. to treat ADHD. FDA approved the once-daily, extended-release liquid methylphenidate last September. Quillivant XR was …
Published on 1/21/2013
-
Pronova Biopharma ASA (OSE:PRON), Lysaker, Norway Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Endocrine/Metabolic Takeda launched Lotriga in Japan to treat hyperlipidemia. Takeda has exclusive, …
Published on 1/21/2013